Showing results (1131-1140 of 4,702) with videos related to

Sort By:
Pageof 471
Seminars in Oncology|June 15, 2024
Isolated lung metastases from pancreatic ductal adenocarcinoma (PDAC): Diagnostic and therapeutic challenges of a different diseaseOrsi Giulia, Bandiera Alessandro, Carretta Angelo, et al.
Seminars in Oncology|November 29, 2025
The role of circular RNAs in driving cancer advancement in low-oxygen conditionsHamza Abu Owida, Raed Obaid Saleh, Suleiman Ibrahim Mohammad, et al.
Seminars in Oncology|November 28, 2025
Genome editing of immune checkpoints: CRISPR-mediated PD-1 inhibition in cancerSuleimanIbrahim Mohammad, A K Kareem, Asokan Vasudevan, et al.
Seminars in Oncology|November 22, 2025
Colchicine as an anti-inflammatory agent improving cancer prognosis: A therapeutic repurposing perspectiveSigal Matza Porges, Oded Shamriz, Shlomo Z Ben-Sasson
Seminars in Oncology|December 27, 2023
Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspectsSerafina Martella, Minke Lucas, Michele Porcu, et al.
Seminars in Oncology|January 23, 2024
PARP inhibitors in ovarian cancerIan S Goldlust, Elena Guidice, Jung-Min Lee
Seminars in Oncology|April 1, 2026
SUMOylation networks drive glioblastoma stemness, microenvironmental remodeling, and resistanceAmmar Yasir Ahmed, Muhammad Ikram Ullah, K D V Prasad, et al.
Seminars in Oncology|May 8, 2026
Risk of intensive care unit admission after immune checkpoint inhibitor use in cancerMaun R Baral, Sambhawana Bhandari, Daniel Morgensztern, et al.
Seminars in Oncology|May 12, 2026
Therapeutic potential of natural triterpenoids in pancreatic cancerChengu Niu, Yujing Han, Jing Zhang, et al.
Seminars in Oncology|December 10, 2009
Gender-associated differences in lung cancer: clinical characteristics and treatment outcomes in womenSeema Harichand-Herdt, Suresh S Ramalingam
Pageof 471